Collegium Pharmaceutical (COLL) Free Cash Flow (2014 - 2026)

Collegium Pharmaceutical has reported Free Cash Flow for 13 years, with the latest figure at $70.8 million in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 2.14% year-over-year to $70.8 million in Q2 2026; TTM through Jun 2026 was $328.3 million, a 62.67% increase from a year earlier, with the FY2025 full-year figure at $327.6 million, up 61.11% from the prior year.
• Free Cash Flow was $70.8 million for Q2 2026 at Collegium Pharmaceutical, up from $56.8 million in the prior quarter.
• The five-year high for Free Cash Flow was $122.4 million in Q4 2025, with the low at -$25.4 million in Q1 2022.
• Average Free Cash Flow over 5 years is $58.6 million, with a median of $66.3 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 226.22% in 2022, then jumped 946.59% in 2025.
• Over 5 years, Free Cash Flow stood at $65.4 million in 2022, then increased by 11.91% to $73.2 million in 2023, then climbed by 14.9% to $84.1 million in 2024, then soared by 45.54% to $122.4 million in 2025, then sank by 42.12% to $70.8 million in 2026.
• The last three Free Cash Flow figures came in at $70.8 million (Q2 2026), $56.8 million (Q1 2026), and $122.4 million (Q4 2025), per Business Quant data.